drugset / Trial / NCT05363891
Natrunix or Placebo in Combination With Methotrexate in Rheumatoid Arthritis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Phase II, Double-Blind, Placebo-Controlled, Randomized Trial Examining Natrunix in Combination with MTX (+Folate) for the Treatment of Rheumatoid Arthritis
Timeline
- Start
- 2023-08-08
- Primary completion
- 2024-10-31
- Completion
- 2024-10-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Natrunix | Monoclonal antibody | 200 mg | Subcutaneous |
| Subject | Natrunix | Monoclonal antibody | 400 mg | Subcutaneous |